Measurement of total urinary proteins in individuals that tested positive by urinary dipstick is a typical method for assessing the presence of potentially serious renal disorders. In the absence of such overt proteinuria, however, measurement of specific urinary proteins may be useful in the diagnosis of nephropathies and may provide greater insight into the pathogenesis. The urine of 28 dogs (16 with renal disease and 12 healthy) was evaluated to determine whether specific low-molecular-weight proteins or the pattern of protein excretion could also be used as a marker of tubular dysfunction in dogs. Specific proteins were assessed by immunological methods, whereas protein profiles were determined by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (MS). In particular, changes in the excretion of retinol-binding protein (RBP) and Tamm-Horsfall protein (THP) appear to be of clinical relevance in the diagnosis of canine kidney diseases. The pattern of urinary protein and peptides revealed specific changes in abundance in dogs with renal disease at molecular masses (kD) of 11.58, 12.41, 12.60, 14.58, 20.95 (RBP), 27.85, and 65.69 (albumin). In conclusion, comparable proteins as in humans might be used as urinary markers for proximal (RBP) and distal (THP) tubular dysfunction in dogs. Surface-enhanced laser desorption/ionization time-of-flight MS is a promising tool for the study of kidney physiology and pathophysiology and might aid in the discovery of new biomarkers of renal disease.
Renal disease in dogs is usually evaluated on the basis of serum or urinary parameters. Serum urea nitrogen and serum creatinine (sCr) concentrations provide a crude index of the glomerular filtration rate (GFR). Inasmuch as the creatinine concentration is influenced by fewer extrarenal variables and creatinine is not resorbed by the renal tubules, sCr is a better index of GFR than serum urea nitrogen. However, these do not exactly define the degree and location of renal damage. In addition, because of the kidney's considerable ability to increase functional capacity in response to injury, a substantial reduction in renal mass (Ͼ75%) must occur before the onset of clinical signs or biochemical alterations becomes manifest. 24 Therefore, measurement of GFR can provide more accurate information about renal excretory function. Because proteinuria is a hallmark of systemic disease in dogs, urinalyses are commonly performed during clinical evaluations. Classically, if urine protein dipstick-positive results are detected, the semiquantitative urine protein-creatinine ratio (upc) is determined, and, if abnormal, further workup is recommended.
Although several grams of protein are filtered daily in the glomeruli, urine is virtually devoid of proteins under physiological conditions. Several key receptors appear to be involved in the resorption of proteins and other vital substances such as different vitamins in complex with their binding proteins. Recent research has established megalin, a 600-kD protein belonging to the low-density lipoprotein receptor gene family, as probably the most important receptor in this process in the proximal tubule mediating endocytosis of a large variety of ligands. 6 Urinary protein excretion, especially with regard to low-molecular-weight (LMW) proteins such as N-acetyl-glucosaminidase, alanin-aminopetidase, neutral endopeptidase, ␣1-microglobulin, retinol-binding protein (RBP), and ␤2-microglobulin, has been described as a reliable marker in evaluating proximal tubular function. 3, 8, 27 Therefore, quantitative and qualitative analyses of urinary proteins have been used to study renal physiology and as a diagnostic tool in renal and systemic diseases. Western blotting and other immunological methods were the most successful techniques used previously to identify urinary proteins in humans. 18, 31 These techniques are, however, limited by the availability of specific antibodies, especially with regard to dogs and other companion animals, and by the possibility of examining only a few proteins at a time. Thus, the possibility of examining the expression of a large number of urinary proteins simultaneously would represent a significant technical advance. Therefore, a novel approach to biomarker discovery was conducted that combines 2 powerful techniques: chromatography and mass spectrometry (MS). This process is known as surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) MS. In humans this technique has proven to be useful in the discovery of potential diagnostic markers for prostate, bladder, and ovarian cancers, as well as Alzheimer's disease. 1, 2, 34, 35 Recently, it has been demonstrated that profiling of urinary proteins by SELDI TOF-MS could be applied to assess renal function in rats. 14 Compared with humans, little information with regard to the quantitative and qualitative importance of urinary LMW proteins for diagnosis of kidney function is available for animals, especially the dog. 4, 13, 17 Because of the clinical relevance of kidney diseases in dogs, the purpose of this study was to evaluate specific proteins known to be valid markers of kidney function in humans, use SELDI-TOF MS for determining differences in urinary protein profiles in dogs with underlying renal diseases, and identify possible new biomarkers of canine renal dysfunction.
Materials and methods
Dogs. The study population comprised 28 dogs (16 dogs with renal disease and 12 healthy dogs). Dogs included in the diseased group had at least one of the following criteria: renal azotemia or renal proteinuria with an abnormal upc. The reference range for this study was sCr Ͼ123 mol/liter, serum urea concentration (sUrea) Ͼ8.3 mmol/liter, and a upc Ն1. Fourteen dogs of this group were males, and 2 were females. Ages ranged from 2 to 16 yr (median 10 yr). Dogs considered clinically normal based on findings of physical examination, hemograms, serum biochemical analysis, and urinalysis were included in the healthy group. A upc below 0.5 was defined as normal. In this group, 10 dogs were males and 2 females. Their ages were between 1 and 12 yr (median age 6 yr).
Laboratory analysis. For analysis, urine samples were collected from each dog by catheterization. The material was stored at Ϫ20Њ C until it was assayed within 3 mo. Each urine sample was centrifuged before the assay for 10 min at approximately 1,500 ϫ g. A blood sample was taken at the same time for hemogram and serum biochemical analysis. Urinary total protein (uProt) was determined by the biuret method. A routine laboratory assay was used to determine sCr, urinary creatinine concentration (uCr), and sUrea as described elsewhere. a, 22 The upc, defined as the ratio of uProt (mg/dl) to uCr (mg/dl), was used to estimate the degree of proteinuria. 12 To compare variables the uCr concentration was used as a common denominator to correct uProt excretion.
Gel electrophoresis and Western blotting. Electrophoretic separations of urinary proteins from both groups and Western blotting procedures were performed as described previously. 28 Briefly, proteins were first separated by 12% sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Thereafter, proteins were transferred to an Immobilon polyvinylidene difluoride membrane. b The blots were fixed with 20% methanol; blocked with Tris-buffered saline (TBS), 0.01% Tween-20, pH 7.6, containing 5% defatted milk, for 1 hr; washed twice with TBS; and then probed with either rabbit anti-human retinol-binding protein or primary sheep antihuman Tamm-Horsfall protein (THP) and secondary rabbit anti-sheep horseradish peroxidase (HRP)-conjugated IgG. c-e Finally, the immunoreactive bands were observed by the enhanced chemiluminescence kit according to the manufacturer's instruction. f Peptide and protein profiling. All urine samples were analyzed by SELDI-TOF MS. Proteins were enriched on a strong anionic exchange array with cationic, quaternary ammonium groups as spot surfaces that interact with the negative charges on the surface of target. g The spot surfaces were first equilibrated by loading 300 l of binding buffer (Tris-HCl buffer 0.1 M, pH 8.5, 0.02% Triton X-100) and incubated for 10 min at 30Њ C. Subsequently, 200 l of sample was mixed with 100 l of binding buffer and added to the spot surface. Peptides and proteins were captured on the strong anion exchange surface after incubation for 30 min at 30Њ C and shaking at 220-250 rpm. h Unbound proteins and other contaminants were removed from the chip surface by washing the chip spot for 5 min with 300 l binding buffer. This step was repeated 3 times. Thereafter, the arrays were rinsed twice for a few seconds with 8 ml deionized distilled water in a 15-ml conical centrifuge tube. Finally, 1 l of a saturated energy-absorbing molecule solution (sinapinic acid dissolved in 50% acetonitrile and 0.5% trifluoroacetic acid) was applied to the spot surface, and the sample was allowed to dry. i After insertion of the ProteinChip Array into the ProteinChip Reader, a laser pulse was focused on the sample under vacuum. j Time-of-flight mass spectra were collected with a ProteinChip System, using the corresponding software. k,l Spectra were collected in the positive-ion mode. Real-time signal averages of 120 laser shots were used to generate each spectrum. Cytochrome c (equine cardiac; 12,360.1 MW), myoglobin (equine cardiac; 16,951.5 MW), glyceraldehyde-3-phosphate dehydrogenase (rabbit; 35,688 MW), albumin (bovine serum; 66,433 MW), and ␤galatosidase (Escherichia coli; 116,351 MW) were used as calibrators. m Identification of albumin (65,712 D, Swiss-Prot P49822) from dogs' urine samples, based on mass, was performed using the Swiss-Prot protein database, allowing 0.1% error in the observed mass. Peaks with amplitudes at least 3 times greater than the average background noise level were considered. The reproducibility was tested by deposing different aliquots of the same urine sample on 8 different spots of the ProteinChip Array.
Statistical analysis. Statistical analysis was done by nonparametric procedures. The Mann-Whitney U-rank test was used to test for significant differences between groups. Values of P Ͻ0.05 were considered significant.
Results
Median values differed significantly between the 16 dogs with chronic renal disease (CRD) and the 12 healthy control dogs for sUrea (P Ͻ 0.001) and sCr (P Ͻ 0.001) ( Table 1 ). There was variation in the magnitude of azotemia among the 16 dogs with CRD. Seven dogs had sCr values between 130 and 221 mol/ liter, 3 dogs had concentrations Ͼ221 mol/liter, and 4 dogs had concentrations Ͼ442 mol/liter. At least 2 dogs had sCr values under 123 mol/liter and also sUrea values under 8.3 mmol/liter, but both showed an abnormal urinary protein loss with a upc above 1.6. There was no significant difference in the concentrations of uProt, but median uCr concentrations were significantly (P Ͻ 0.001) lower in the dogs with renal disease than in the control dogs. Using the upc, dogs with renal disease showed significant proteinuria when compared with the controls (P Ͻ 0.001). Two dogs had a upc between 0.5 and 1, 3 dogs had a upc between 1 and 2, and 8 dogs had a upc above 3. But in the group of diseased dogs, 3 dogs also had a upc below 0.5. Urine specific gravity for dogs with CRD was significantly (P Ͻ 0.001) lower than urine specific gravity for control dogs. Analysis of urine sediment for dogs with CRD revealed few red blood cells, white blood cells, or epithelial cells. Various types of casts (hyaline, granular, and waxy) were found in urine sediments of 9 dogs with renal disease.
Retinol-binding protein and THP were selected because their concentration in urine reflects the function of the proximal and the distal renal tubules, respectively. Using Western blotting, both proteins were found to be present in urine. Whereas RBP was present only in sick dogs, THP was present in the urine of healthy dogs as well as those with renal impairment. Immunoreactive RBP was detected at a molecular mass of 21 kD (Fig. 1a) . In contrast to RBP, THP was present in the urine of all healthy dogs, but most of the affected dogs had little or no THP in the urine. Immunoreactive THP was detected at a molecular mass of 100 kD (Fig. 1b) .
As an initial study to ascertain the potential of ProteinChip Arrays and SELDI-TOF MS, a number of urine samples were prepared and analyzed using different chip surfaces. Using the strong anionic exchanger protein chip, the best results for urinary protein profiling were received. After SELDI-TOF MS, approximately 30-200 peptide and protein peaks were observed in each sample. In general, urine samples from affected dogs had a much higher number of individual peaks (about 90-200) than those from healthy ones (about 30-40). Figure 2 compares a typical protein pattern in the molecular mass range of 10-70 kD in diseased and healthy dogs after SELDI-TOF procedure. Figure 3 summarizes the mass intensities of 7 proteins selected by the Ciphergen Biomarker Wizard software to be significantly different (11.58 and 14.58 kD, P Ͻ 0.001; 12.41, 12.60, 20.95, and 27.85 kD, P Ͻ 0.01; and 65.69 kD, P Ͻ 0.02). All these proteins, except the one with a molecular mass of 27.85 kD, were elevated in renal disease. Regarding the 27.85-kD protein, however, there were not only quantitative but also qualitative differences. In the urine of affected dogs the average molecular mass of this protein was 380 D lower than that in the urine of healthy dogs.
Discussion
Determination of the protein and peptide composition of urine may lead to an improved understanding of renal physiology and offer new insights into the pathogenesis of various renal diseases. In the present study characteristic proteins in dogs with renal disease were identified using both classical immunological detection (Western blotting) and a novel proteomic technology: SELDI-TOF MS.
In proteomic research it is generally accepted that a single protein isolation method will not be able to identify the whole proteome. This is because of the variability in physical and chemical properties of proteins and their wide, dynamic range in concentration in different biologic fluids. Two-dimensional (2D)-gel electrophoresis is an important method for the separation of many proteins in a given sample. Typically, proteins are first separated by their isoelectric point (pl) (first dimension) and then by their electrophoretic mobility (second dimension), followed by staining of the polyacrylamid gel for observation. The efficient separation of larger proteins and the ability to handle high amounts of total protein content are unequivocal advantages of the 2D-gel electrophoresis. On the other hand, because of its slowness and difficulties in reproducibility, it is not suitable for high-throughput analysis. In comparison, SELDI-TOF MS needs only small amounts of sample and delivers reliable and reproducible data in a very short time. Thus, it is an extremely useful tool especially for comparative profiling and biomarker discovery, as has been shown in the study of a variety of cancers and degenerative diseases. 9, 35 In contrast to 2D-gel analysis, SELDI-TOF MS protein profiling relies on the affinities of proteins and peptides to a specific chromatographic surface. Many proteins formerly masked by others in the crude sample are visible after this separation for the very first time, increasing the chances of finding novel biomarkers. Furthermore, proteins with an MW below 25 kD and those with extremes of hydrophobicity or isoelectric point are more easily accessible compared with the 2D-gel approach. Moreover, SELDI analysis is independent of species and allows peptide and protein pro-filing from a variety of complex biological materials such as serum, urine, cell lysate, and cellular secretion products with simple sample preparation. The peak data obtained require highly ordered data-mining operations for analysis, which are offered by special SELDI software for comparing data sets. The SAX2 ProteinChip Array was chosen for urine profiling because of previous experiments that have been successful with the described set of binding and washing conditions. Typically, chemically treated surfaces like the cationic, quaternary ammonium groups on the SAX2 ProteinChip Array retain whole classes of proteins, which is important for profiling procedures. The pl of a protein will strongly influence how well it binds to the ionic ProteinChip Array. Proteins with a low pl bind strongly to the anion exchange surface (SAX2). If the buffer solution is lowered below the pl of the protein, the protein will begin to bear a net positive charge and will bind more weakly to the surface of the array, whereas proteins with a high pl bind strongly to a cation exchange surface. Urine contains proteins with a low as well as a high pl. The choice of the used binding and washing conditions with a pH of 8.5 permits the retention of a large number of urinary proteins as indicated by the results.
Urine is an easily obtainable biological fluid containing a number of components that can be relevant biomarkers of renal dysfunction and various other diseases. 10 In humans several LMW urinary proteins are generally used to assess renal dysfunction with regard to glomerular filtration and tubular reabsorption. The urinary excretion of RBP is a specific index of proximal tubular dysfunction because RBP normally filtered through the glomeruli is reabsorbed by the megalin receptor in the proximal tubule cells. 5, 7, 15 Retinolbinding protein loss is greater in nephropathies with tubular lesions than in those with glomerular lesions because of a failure of reabsorption and metabolism by proximal tubular epithelial cells. 26, 32 In accordance with these results in humans, it was possible to show with both analyzing techniques, Western blotting and SELDI-TOF MS, that RBP was present only in the urine of dogs with kidney diseases (Figs. 1a, 2) .
A marker for distal tubular function, THP, which has proven useful in humans, was also studied. Tamm-Horsfall protein is a urinary glycoprotein exclusively synthesized by tubular cells in the distal part of the nephron. 29 It is normally found in the urine of humans and also in canids. 11, 23 In the presence of chronic renal failure in humans, THP excretion was found to be reduced and correlated with overall renal function as assessed by creatinine clearance. 19, 25, 33 This observation is also in accordance with findings of this study showing a reduced urinary excretion of THP in affected dogs (Fig. 1b) . The function of the distal tubule cells is likely to be reduced in chronic nephropathy, and it is possible that the urinary excretion rate of THP reflects the protein-synthesizing activity of distal tubular cells in patients with chronic nephropathy. 33 Regarding these results, one can conclude that the human tubular markers RBP and THP are also highly selective markers of proximal and distal tubular injury in dogs, respectively.
In addition to the characterization of specific markers of kidney function by immunoblotting, the present study is able to show other urinary proteins that might be potential candidates as markers of kidney physiology and pathophysiology. Given the excellent sensitivity of the SELDI-TOF MS detection, increased amounts of proteins in canine urine can be identified through an increase in protein peak intensity. The urine of the dogs showed a great heterogeneity in their protein profiles. Only 7 proteins were found to be significantly different in the urine of diseased versus healthy dogs (P Ͻ 0.05). Two proteins (the 11.58-and the 14.58-kD proteins) were of very high statistical significance (P Ͻ 0.001). The protein peak with the molecular mass of 11.58 kD shows the highest sensitivity in SELDI analysis. This protein appeared to be the best discriminator between dogs with renal disease and healthy dogs (Fig. 3) .
Because of the very few sequence data available for canine proteins despite high mass accuracy, the identification based on the molecular mass can be only tentative. Based on previous studies the protein with an MW of 11.58 kD could be ␤2-microglobulin; 20 the protein with 21-kD MW, RBP; and that with 65.69-kD MW, albumin. 30 All these proteins are known to be excreted increasingly as a consequence of kidney dysfunction. An increased urinary excretion of ␤2-microglobulin correlates with a high incidence of tubulointerstitial lesions in patients with renal diseases. 21 To confirm the results for other proteins, further analysis of a higher sample number is required. Therefore, SELDI-TOF MS offers the possibility of analyzing samples by a high-throughput method. The urine proteome changes constantly as a consequence of perfusion of the diseased organ. These disease-related differences in protein levels could be the result of proteins being overexpressed or abnormally shed. They could be clipped or modified as a consequence of the disease process or subtracted from the proteome owing to abnormal activation of the proteolytic degradation pathway. It is generally recognized that the metabolism of filtered proteins in the kidney occurs through lysosomal activity in proximal tubular cells. 16 Studies of bioinformatic analysis predicted glycosylation to be the most common explanation for multiple forms of the same protein. 31 This could also occur for the pro-tein with an MW of 27.85 kD, which differs by 380 D between the 2 groups studied.
In conclusion, this study shows that RBP and THP may be used as valid markers of kidney function in dogs and emphasizes the importance of specific markers to assess properly the location and extent of renal disease. Of particular note is the fact that 5 dogs had a upc below the utilizing cutoff (upc Ͼ1) while showing an abnormal protein profile. The data presented here demonstrate the applicability of SELDI-TOF MS in detecting unique urinary proteins in dogs associated with renal damage. The results indicate that it is possible to identify a typical pattern of urinary proteins in canine renal damage. The identification of the 7 urinary proteins, which differ significantly between healthy dogs and dogs with renal disease, and their expression site may provide a new urinary marker in canine renal disease. Furthermore, these methods could provide accurate information to determine the onset of functional renal impairment. Possibly, they could give strategies to prevent or slow the decline of renal function in dogs. The identification of novel urinary proteins may lead to an enhanced understanding of renal physiology and pathophysiology and thus lead to the discovery of new ''biomarkers'' of kidney disease in the dog and other species.
